Diabetes insipidus pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
The posterior pituitary consists of paraventricular and the supra-optic nuclei that synthesizes oxytocin and arginine vasopressin respectively. In Central DI, there is an absence of vasopressin which is responsive to the exogenous administration of desmopressin. On the contrary, in nephrogenic DI, solute excretion and all filtration functions of the kidney are normal but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of both endogenous and exogenous administration of vasopressin. More than 55 different genetic mutations resulting in a defective prohormone and a deficiency of AVP have been identified in familial central diabetes. Many conditions have been associated with the development of diabetes insipidus such as Wolfram syndrome also known as DIDMOAD, Langerhans cell histiocytosis (LCH),  sickle   cell   disease, amyloidosis etc.
The [[posterior pituitary]] consists of [[Paraventricular nucleus of hypothalamus|paraventricular]] and the supra-optic nuclei that synthesizes [[oxytocin]] and [[arginine vasopressin]] respectively. In [[Central diabetes insipidus|Central DI]], there is an absence of [[vasopressin]] which is responsive to the exogenous administration of [[desmopressin]]. On the contrary, in [[Nephrogenic diabetes insipidus|nephrogenic DI]], [[solute]] excretion and all filtration functions of the [[kidney]] are normal but [[urine]] is [[hypotonic]] and there is a characteristic resistance to the [[antidiuretic]] effects of both [[endogenous]] and [[exogenous]] administration of [[vasopressin]]. More than 55 different genetic mutations resulting in a defective [[prohormone]] and a deficiency of [[AVP]] have been identified in familial [[Central diabetes insipidus|central diabetes]]. Many conditions have been associated with the development of diabetes insipidus such as [[Wolfram syndrome]] also known as DIDMOAD, [[Langerhans cell histiocytosis]] (LCH),  [[Sickle-cell disease|sickle cell disease]], [[amyloidosis]] etc.


==Pathogenesis==
==Pathogenesis==
===Central Diabetes insipidus===
===Central Diabetes insipidus===
The posterior pituitary consists of paraventricular and the supra-optic nuclei that synthesizes oxytocin and arginine vasopressin respectively. The axons of these hormones project to the neurohypophysis where the hormones are secreted into the blood stream to allow maximum antidiuresis for 5–10 days.
The [[posterior pituitary]] consists of [[Paraventricular nucleus|paraventricular]] and the supra-optic nuclei that synthesizes [[oxytocin]] and [[arginine vasopressin]] respectively. The [[axons]] of these [[hormones]] project to the [[neurohypophysis]] where the [[hormones]] are secreted into the [[blood stream]] to allow maximum antidiuresis for 5–10 days. The maintenance of water balance in healthy humans is achieved principally by three interrelated determinants:  
The maintenance of water balance in healthy humans is achieved principally by three interrelated determinants:  
*[[Thirst]]
*Thirst
*[[AVP]]
*AVP  
*[[Kidney]] function
*Kidney function
[[AVP]] acts on the [[kidney]], where it increases [[urine osmolality]]. It binds to the V2-receptors in the [[basolateral membrane]] of the [[Collecting duct system|renal collecting tube]] and activates the Gs-adenyl cyclase system, increasing intracellular levels of [[Cyclic adenosine monophosphate|cyclic 3′,5′-adenosine monophosphate]] ([[Cyclic adenosine monophosphate|cAMP]]) activating [[protein kinase A]], which in turn phosphorylates preformed AQP2 water channels localized in intracellular vesicles.<ref name="pmid16209125">{{cite journal| author=Agre P| title=Nobel Lecture. Aquaporin water channels. | journal=Biosci Rep | year= 2004 | volume= 24 | issue= 3 | pages= 127-63 | pmid=16209125 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16209125  }} </ref>
AVP acts on the kidney, where it increases urine osmolality. It binds to the V2-receptors in the basolateral membrane of the renal collecting tube and activates the Gs-adenyl cyclase system, increasing intracellular levels of cyclic 3′,5′-adenosine monophosphate (cAMP) activating protein kinase A, which in turn phosphorylates preformed AQP2 water channels localized in intracellular vesicles.<ref name="pmid16209125">{{cite journal| author=Agre P| title=Nobel Lecture. Aquaporin water channels. | journal=Biosci Rep | year= 2004 | volume= 24 | issue= 3 | pages= 127-63 | pmid=16209125 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16209125  }} </ref>


=== Nephrogenic diabetes insipidus ===
=== Nephrogenic diabetes insipidus ===
In nephrogenic DI, solute excretion and all filtration functions of the kidney are normal but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of endogenous vasopressin. Abnormalities in the medullary osmotic  gradient  directed  by  antidiuretic  hormone (ADH) or arginine vasopressin (AVP) and inhibition of the action of ADH  on  the  renal tubules  are both thought to be mechanisms of development of nephrogenic DI. The lack of response to  ADH  is  due  to the  inhibition  of  adenylate cyclase  and  resultant  decreased  formation  of cyclic  cAMP.  cAMP  serves  as  a  second  messenger  to  protein  kinase  A  and  the  fusion  of aquaporin  storage  vesicles  to  the  luminal  cell wall, which in turn allows the collecting ducts to become  permeable  and  reabsorb  water.
In [[Nephrogenic diabetes insipidus|nephrogenic DI]], [[solute]] [[excretion]] and all [[filtration]] functions of the [[kidney]] are normal but [[urine]] is [[hypotonic]] and there is a characteristic resistance to the [[antidiuretic]] effects of [[endogenous]] [[vasopressin]]. Abnormalities in the [[medullary]] [[osmotic]] [[gradient]] directed  by  [[antidiuretic  hormone]] ([[ADH]]) or [[arginine vasopressin]] ([[AVP]]) and inhibition of the action of [[ADH]] on  the  [[renal tubules]] are both thought to be mechanisms of development of [[Nephrogenic diabetes insipidus|nephrogenic DI]]. The lack of response to  [[ADH]] is  due  to the  inhibition  of  [[adenylate cyclase]] and  resultant  decreased  formation  of [[Cyclic adenosine monophosphate|cAMP]][[cAMP]] serves  as  a  second  messenger  to  [[Protein kinase A|protein  kinase  A]] and  the  fusion  of [[aquaporin]] storage  vesicles  to  the  [[luminal]] cell wall, which in turn allows the [[Collecting duct system|collecting ducts]] to become  permeable  and  reabsorb  water.


==Genetics==
==Genetics==
*More than 55 different genetic mutations resulting in a defective prohormone and a deficiency of AVP have been identified in familial central diabetes.<ref name="ChristensenRittig2006">{{cite journal|last1=Christensen|first1=Jane H.|last2=Rittig|first2=Søren|title=Familial Neurohypophyseal Diabetes Insipidus—An Update|journal=Seminars in Nephrology|volume=26|issue=3|year=2006|pages=209–223|issn=02709295|doi=10.1016/j.semnephrol.2006.03.003}}</ref><ref name="GhirardelloGarrè2007">{{cite journal|last1=Ghirardello|first1=S.|last2=Garrè|first2=M.-L.|last3=Rossi|first3=A.|last4=Maghnie|first4=M.|title=The Diagnosis of Children with Central Diabetes Insipidus|journal=Journal of Pediatric Endocrinology and Metabolism|volume=20|issue=3|year=2007|issn=2191-0251|doi=10.1515/JPEM.2007.20.3.359}}</ref>
*More than 55 different genetic mutations resulting in a defective [[prohormone]] and a deficiency of [[AVP]] have been identified in familial [[Central diabetes insipidus|central diabetes]].<ref name="ChristensenRittig2006">{{cite journal|last1=Christensen|first1=Jane H.|last2=Rittig|first2=Søren|title=Familial Neurohypophyseal Diabetes Insipidus—An Update|journal=Seminars in Nephrology|volume=26|issue=3|year=2006|pages=209–223|issn=02709295|doi=10.1016/j.semnephrol.2006.03.003}}</ref><ref name="GhirardelloGarrè2007">{{cite journal|last1=Ghirardello|first1=S.|last2=Garrè|first2=M.-L.|last3=Rossi|first3=A.|last4=Maghnie|first4=M.|title=The Diagnosis of Children with Central Diabetes Insipidus|journal=Journal of Pediatric Endocrinology and Metabolism|volume=20|issue=3|year=2007|issn=2191-0251|doi=10.1515/JPEM.2007.20.3.359}}</ref>
*Majority have an autosomal dominant form of inheritance
*Majority have an [[autosomal dominant]] form of inheritance


==Associated Conditions==
==Associated Conditions==
*Langerhans cell histiocytosis (LCH)
*[[Langerhans cell histiocytosis]] (LCH)
*Wolfram syndrome also known as DIDMOAD
*[[Wolfram syndrome]] also known as DIDMOAD
*Sickle   cell   disease
*[[Sickle-cell disease|Sickle cell disease]]
*Amyloidosis
*[[Amyloidosis]]
*Obstructive uropathy
*[[Obstructive uropathy]]
*Electrolyte disorders (e.g.,hypokalemia  and  hypercalcemia)   
*Electrolyte disorders (e.g.,[[hypokalemia]] and  [[hypercalcemia]])   
*Pregnancy
*[[Pregnancy]]
*Conditions  induced  by a drug  (e.g.,  lithium, demeclocycline, Amphotericin      B       and
*Conditions  induced  by a drug  (e.g.,  [[lithium]], [[demeclocycline]], [[amphotericin B]] and [[vincristine]])
vincristine)
 
*Lithium  is  the  most  common cause of drug-induced nephrogenic DI
*[[Lithium]] is  the  most  common cause of drug-induced [[Nephrogenic diabetes insipidus|nephrogenic DI]]
==Gross Pathology==
==Gross Pathology==
There are no gross pathology findings associated with diabetes insipidus.
There are no gross pathology findings associated with diabetes insipidus.

Revision as of 13:01, 17 July 2017

Diabetes insipidus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diabetes insipidus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diabetes insipidus pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diabetes insipidus pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diabetes insipidus pathophysiology

CDC on Diabetes insipidus pathophysiology

Diabetes insipidus pathophysiology in the news

Blogs on Diabetes insipidus pathophysiology

Directions to Hospitals Treating Diabetes insipidus

Risk calculators and risk factors for Diabetes insipidus pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The posterior pituitary consists of paraventricular and the supra-optic nuclei that synthesizes oxytocin and arginine vasopressin respectively. In Central DI, there is an absence of vasopressin which is responsive to the exogenous administration of desmopressin. On the contrary, in nephrogenic DI, solute excretion and all filtration functions of the kidney are normal but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of both endogenous and exogenous administration of vasopressin. More than 55 different genetic mutations resulting in a defective prohormone and a deficiency of AVP have been identified in familial central diabetes. Many conditions have been associated with the development of diabetes insipidus such as Wolfram syndrome also known as DIDMOAD, Langerhans cell histiocytosis (LCH), sickle cell disease, amyloidosis etc.

Pathogenesis

Central Diabetes insipidus

The posterior pituitary consists of paraventricular and the supra-optic nuclei that synthesizes oxytocin and arginine vasopressin respectively. The axons of these hormones project to the neurohypophysis where the hormones are secreted into the blood stream to allow maximum antidiuresis for 5–10 days. The maintenance of water balance in healthy humans is achieved principally by three interrelated determinants:

AVP acts on the kidney, where it increases urine osmolality. It binds to the V2-receptors in the basolateral membrane of the renal collecting tube and activates the Gs-adenyl cyclase system, increasing intracellular levels of cyclic 3′,5′-adenosine monophosphate (cAMP) activating protein kinase A, which in turn phosphorylates preformed AQP2 water channels localized in intracellular vesicles.[1]

Nephrogenic diabetes insipidus

In nephrogenic DI, solute excretion and all filtration functions of the kidney are normal but urine is hypotonic and there is a characteristic resistance to the antidiuretic effects of endogenous vasopressin. Abnormalities in the medullary osmotic gradient directed by antidiuretic hormone (ADH) or arginine vasopressin (AVP) and inhibition of the action of ADH on the renal tubules are both thought to be mechanisms of development of nephrogenic DI. The lack of response to ADH is due to the inhibition of adenylate cyclase and resultant decreased formation of cAMP. cAMP serves as a second messenger to protein kinase A and the fusion of aquaporin storage vesicles to the luminal cell wall, which in turn allows the collecting ducts to become permeable and reabsorb water.

Genetics

Associated Conditions

Gross Pathology

There are no gross pathology findings associated with diabetes insipidus.

Microscopic Pathology

There are no microscopic findings associated with diabetes insipidus.

References

  1. Agre P (2004). "Nobel Lecture. Aquaporin water channels". Biosci Rep. 24 (3): 127–63. PMID 16209125.
  2. Christensen, Jane H.; Rittig, Søren (2006). "Familial Neurohypophyseal Diabetes Insipidus—An Update". Seminars in Nephrology. 26 (3): 209–223. doi:10.1016/j.semnephrol.2006.03.003. ISSN 0270-9295.
  3. Ghirardello, S.; Garrè, M.-L.; Rossi, A.; Maghnie, M. (2007). "The Diagnosis of Children with Central Diabetes Insipidus". Journal of Pediatric Endocrinology and Metabolism. 20 (3). doi:10.1515/JPEM.2007.20.3.359. ISSN 2191-0251.

Template:WH Template:WS